Fingerprint
Dive into the research topics of 'A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically